Get the Stockscreener App
6.80
0.44%
-0.03
Neuehealth Inc stock is traded at $6.80, with a volume of 7,507.
It is down -0.44% in the last 24 hours and down -0.73% over the past month.
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
See More
Previous Close:
$6.83
Open:
$6.8762
24h Volume:
7,507
Relative Volume:
1.04
Market Cap:
$60.71M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.44%
1M Performance:
-0.73%
6M Performance:
-7.61%
1Y Performance:
+32.55%
1-Day Range:
$6.80
$6.90
1-Week Range:
$6.79
$6.91
52-Week Range:
$3.79
$7.66
Neuehealth Inc Stock (NEUE) Company Profile
Name
Neuehealth Inc
Sector
Industry
Phone
612-238-1321
Address
9250 NW 36TH STREET, DORAL
Compare NEUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
6.80 | 60.98M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
300.40 | 275.51B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CVS
Cvs Health Corp
|
64.45 | 84.35B | 378.96B | 5.28B | 5.94B | 4.19 |
|
CI
Cigna Group
|
302.82 | 83.78B | 254.47B | 5.03B | 6.01B | 18.06 |
|
ELV
Elevance Health Inc
|
340.08 | 78.37B | 183.12B | 5.92B | 3.67B | 25.63 |
|
HUM
Humana Inc
|
228.52 | 28.63B | 117.76B | 1.21B | 2.39B | 9.95 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-29-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-04-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-22 | Downgrade | BofA Securities | Buy → Underperform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-10-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-12-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-02-21 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-04-21 | Upgrade | Citigroup | Neutral → Buy |
| Aug-04-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-19-21 | Initiated | Goldman | Buy |
| Jul-19-21 | Initiated | JP Morgan | Neutral |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | RBC Capital Mkts | Outperform |
| Jul-19-21 | Initiated | Wolfe Research | Peer Perform |
View All
Neuehealth Inc Stock (NEUE) Latest News
NeueHealth Stock Soars Toward 9-Month Highs On $1.3B Take-Private Deal: Retail Exuberant - MSN
NeueHealth (NYSE:NEUE) and Oncology Institute (NASDAQ:TOI) Head to Head Comparison - Defense World
Northern Trust Corp Increases Stock Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
NeueHealth Inc Holds Annual Stockholders Meeting - TipRanks
NeueHealth (NYSE:NEUE) Trading Down 2% – What’s Next? - Defense World
How Bright Health went from insurtech darling to cautionary tale - Modern Healthcare
NeueHealth's Q1 2025: Key Contradictions in Consumer Growth, Revenue, and Profitability - AInvest
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - Star Tribune
neueHealth CFO Matushak sells $3,190 in common stock - Investing.com Australia
neueHealth CFO Matushak sells $3,190 in common stock By Investing.com - Investing.com Nigeria
NeueHealth Inc. Reports Strong Start to 2025 - TipRanks
UnitedHealth’s financial miscues, and an $800 million revenue cycle bonanza - statnews.com
NeueHealth, Inc. SEC 10-Q Report - TradingView
NeueHealth Q1 2025 slides: improved margins offset revenue decline - Investing.com
NeueHealth: Q1 Earnings Snapshot - New Haven Register
Earnings call transcript: NeueHealth’s Q1 2025 sees strong consumer growth By Investing.com - Investing.com Nigeria
NeueHealth Inc (NEUE) Q1 2025 Earnings Call Highlights: Strong Consumer Growth and Continued ... By GuruFocus - Investing.com Canada
NeueHealth Inc. Reports Strong Q1 2025 Performance - TipRanks
NeueHealth Inc Approves Merger with NH Holdings - TipRanks
NeueHealth to go private after shareholder vote - Modern Healthcare
NeueHealth Inc reports results for the quarter ended March 31Earnings Summary - TradingView
NeueHealth Q1 2025 slides: improved margins offset revenue decline By Investing.com - Investing.com Nigeria
Earnings call transcript: NeueHealth’s Q1 2025 sees strong consumer growth - Investing.com
NeueHealth, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
NeueHealth Reports First Quarter 2025 Results - Business Wire
NEUEHEALTH Earnings Results: $NEUE Reports Quarterly Earnings - Nasdaq
Renaissance Technologies LLC Sells 1,500 Shares of NeueHealth, Inc. (NYSE:NEUE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Short Interest in NeueHealth, Inc. (NYSE:NEUE) Declines By 65.9% - Defense World
Former Bright Health, once a Minnesota IPO darling, goes private in $1.3B deal - MSN
Investor Sues To Halt 'Cheap' VC Buyout Of Fla. Health Co. - Law360
NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025 - Bluefield Daily Telegraph
NeueHealth Sets Q1 2025 Earnings Date: Key Financial Results Coming May 8 Before Market Open - Stock Titan
NeueHealth (NYSE:NEUE) Trading Up 1.3% – Still a Buy? - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEUE, BRKL, JWN on Behalf of Shareholders - marketscreener.com
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc.NEUE - Business Wire
NeueHealth StockIs the Proposed Acquisition of NeueHealth By An Affiliate of Its Controlling Shareholder Fair to NEUE Shareholders?Kehoe Law Firm, P.C. Investigating - ACCESS Newswire
NeueHealth, Inc. (NYSE:NEUE) Q4 2024 Earnings Call Transcript - MSN
Virtu Financial LLC Takes Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
Judge dismisses part of SSM Health-Bright Health lawsuit - Modern Healthcare
NeueHealth Inc. Earnings Call Highlights Growth and Acquisition - TipRanks
NeueHealth Inc. (NEUE) reports earnings - Quartz
NeueHealth: Q4 Earnings Snapshot - Midland Daily News
NeueHealth Inc (NEUE) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
NeueHealth Inc. Reports Strong 2024 Financial Performance - TipRanks
Neuehealth Inc Stock (NEUE) Financials Data
There is no financial data for Neuehealth Inc (NEUE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Neuehealth Inc Stock (NEUE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ADKINS KEDRICK D JR | Director |
May 13 '25 |
Option Exercise |
0.00 |
10,500 |
0 |
16,443 |
| Kadre Manuel | Director |
May 13 '25 |
Option Exercise |
0.00 |
10,500 |
0 |
29,820 |
| Gooden Linda R | Director |
May 13 '25 |
Option Exercise |
0.00 |
10,500 |
0 |
16,443 |
| Sheehy Robert J | Director |
May 13 '25 |
Option Exercise |
0.00 |
10,500 |
0 |
15,255 |
| Makhzoumi Mohamad | Director |
May 13 '25 |
Option Exercise |
0.00 |
10,500 |
0 |
16,443 |
| Kraus Stephen | Director |
May 13 '25 |
Option Exercise |
0.00 |
10,500 |
0 |
16,444 |
| Manders Matthew G | Director |
May 13 '25 |
Option Exercise |
0.00 |
10,500 |
0 |
16,741 |
| Slavitt Andrew M | Director |
May 13 '25 |
Option Exercise |
0.00 |
10,500 |
0 |
18,529 |
| Scherman Jeffrey J | Chief Accounting Officer |
May 12 '25 |
Sale |
6.76 |
112 |
757 |
12,463 |
| Matushak Jay | Chief Financial Officer |
May 12 '25 |
Sale |
6.76 |
472 |
3,191 |
40,556 |
0.24%
2.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):